BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19829139)

  • 1. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
    Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter intracardiac echocardiography-assisted closure of interatrial shunts: complications and midterm follow-up.
    Rigatelli G; Cardaioli P; Giordan M; Dell'Avvocata F; Braggion G; Piergentili C; Roncon L; Faggian G
    Echocardiography; 2009 Feb; 26(2):196-202. PubMed ID: 19207996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
    Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C; Reissmann U; Timmermanns I; Schräder R
    J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.